Long-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications

Cardiovascular Events in Patients With Fabry Disease

(2011) Manesh R. Patel et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Expert opinion on temporary treatment recommendations for Fabry disease during the shortage of enzyme replacement therapy (ERT)

(2010) Gabor E. Linthorst et al.   MOLECULAR GENETICS AND METABOLISM

Long-Term Effects of Enzyme Replacement Therapy on Fabry Cardiomyopathy

(2009) Frank Weidemann et al.   CIRCULATION

A 4-year study of the efficacy and tolerability of enzyme replacement therapy with agalsidase alfa in 36 women with Fabry disease

(2009) Catharina Whybra et al.   GENETICS IN MEDICINE

Natural course of Fabry disease: changing pattern of causes of death in FOS - Fabry Outcome Survey

(2009) A Mehta et al.   JOURNAL OF MEDICAL GENETICS

Screening for Fabry disease in high-risk populations: a systematic review

(2009) G. E. Linthorst et al.   JOURNAL OF MEDICAL GENETICS

Agalsidase Alfa and Kidney Dysfunction in Fabry Disease

(2009) M. West et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data

(2009) A Mehta et al.   LANCET

Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy

(2009) R. Schiffmann et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Stroke in Fabry Disease Frequently Occurs Before Diagnosis and in the Absence of Other Clinical Events

(2009) Katherine Sims et al.   STROKE

Terminal stage cardiac findings in patients with cardiac Fabry disease: An electrocardiographic, echocardiographic, and autopsy study

(2008) Toshihiro Takenaka et al.   Journal of Cardiology

Central nervous system involvement in Anderson-Fabry disease: a clinical and MRI retrospective study

(2008) S Buechner et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Nephropathy in males and females with Fabry disease: cross-sectional description of patients before treatment with enzyme replacement therapy

(2008) A. Ortiz et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Effects of enzyme replacement therapy on the cardiomyopathy of Anderson Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa

(2007) D A Hughes et al.   HEART